Maha Othman: Redefining Hemostasis Through AI-Enabled Peptide Engineering
Maha Othman, Co-Chairman SSC on Disseminated intravascular coagulopathy at International Society on Thrombosis and Haemostasis, shared
Seminars in Thrombosis and Hemostasis‘s post on LinkedIn, adding:
“Delighted to see this published.
Proud of my mentee Thomas Kazmirchuk and collaborator Ashkan Golshani
Look forward to continuing this research to drive innovation towards understanding of disease pathophysiology, diagnosis, and management, especially for the rare bleeding disorders!”
Seminars in Thrombosis and Hemostasis shared a post on LinkedIn about a recent article by Thomas Kazmirchuk et al., adding:
“Excited to share this insightful article on how AI-driven peptide design is shaping the future of hemostasis and precision medicine for bleeding disorders.
A promising step toward more targeted and personalized therapies.”
Title: Designing the Future of Hemostasis
Authors: Thomas D. D. Kazmirchuk , Jiashu Wang, Janice Corbette, Zein Al Abideen Hammad, Maha Othman, Ashkan Golshani
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 25, 2026, 11:26Jonathan Furniss: Reflections on Presenting at the ISTH 2026
-
Jul 25, 2026, 11:17Aryan Mathur: Annexin V and Coagulation Factors in Pulmonary Embolism
-
Jul 25, 2026, 11:04Meghan McCarthy: Closing the Diagnostic Gap in Women with Bleeding Disorders
-
Jul 25, 2026, 10:23Strengthening the Public Health Infrastructure for Blood Disorders- ASH
-
Jul 25, 2026, 10:02Strengthening Haemovigilance in Pediatric Transfusion Medicine – ISBT
-
Jul 25, 2026, 09:33Edward C.C. Wong: Adopting Ferritin Thresholds Over Reference Intervals to Diagnose Iron Deficiency
-
Jul 25, 2026, 09:31Emeka Patrick Chukwuka: The Numbers Don’t Lie, But Context Matters
-
Jul 25, 2026, 08:08Abdulaziz (Omar) Badran: A Reminder That Morphology Still Matters in Modern Hematology
-
Jul 25, 2026, 07:55Syed Ali Shazif Baqari: Essential Guide to Blood Groups and Blood Component Compatibility